These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 35207772)
1. Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis. Pellicano C; Miglionico M; Romaggioli L; Colalillo A; Vantaggio L; Napodano C; Callà C; Gulli F; Marino M; Basile U; Rosato E J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207772 [TBL] [Abstract][Full Text] [Related]
2. Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients. Pellicano C; Colalillo A; Cusano G; Palladino A; Pellegrini M; Callà CAM; Mazzuccato G; Carnazzo V; Pignalosa S; Di Biase L; Marino M; Basile U; Rosato E J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836543 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database. Frantz C; Huscher D; Avouac J; Hachulla E; Balbir-Gurman A; Riemekasten G; Siegert E; Lazzaroni MG; Carreira PE; Vettori S; Zanatta E; Ullman S; Czirjàk L; Kowal-Bielecka O; Distler O; Matucci-Cerinic M; Allanore Y; Autoimmun Rev; 2020 Feb; 19(2):102452. PubMed ID: 31838157 [TBL] [Abstract][Full Text] [Related]
4. Circulating Collagen Metabolites and the Enhanced Liver Fibrosis (ELF) Score as Fibrosis Markers in Systemic Sclerosis. Chen C; Wang L; Wu J; Lu M; Yang S; Ye W; Guan M; Liang M; Zou H Front Pharmacol; 2022; 13():805708. PubMed ID: 35177989 [No Abstract] [Full Text] [Related]
5. Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity. Grosicka A; Manasar A; Kucharz EJ; Kotyla PJ Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):541-549. PubMed ID: 31174823 [TBL] [Abstract][Full Text] [Related]
6. Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis. Rimar D; Rosner I; Nov Y; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Daood R; Vadasz Z Arthritis Rheumatol; 2014 Mar; 66(3):726-30. PubMed ID: 24574233 [TBL] [Abstract][Full Text] [Related]
7. The complement and immunoglobulin levels in NMO patients. Chen Y; Li R; Wu AM; Shu YQ; Lu ZQ; Hu XQ Neurol Sci; 2014 Feb; 35(2):215-20. PubMed ID: 23881468 [TBL] [Abstract][Full Text] [Related]
8. Retrospective comparative study of the efficacy of JAK inhibitor (tofacitinib) in the treatment of systemic sclerosis-associated interstitial lung disease. Junfei Z; Meihua G; Shuai Z; Xiangting L; Zhidan L; Tianming C; Yajing L; Chu T; Lipu S Clin Rheumatol; 2023 Oct; 42(10):2823-2832. PubMed ID: 37335409 [TBL] [Abstract][Full Text] [Related]
9. Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study. Vandecasteele E; Melsens K; Vanhaecke A; Blockmans D; Bonroy C; Carton C; Deschepper E; De Keyser F; Houssiau F; Piette Y; Vanthuyne M; Verbeke K; Westhovens R; Wuyts WA; De Langhe E; Brusselle G; Smith V Semin Arthritis Rheum; 2021 Oct; 51(5):969-976. PubMed ID: 34403812 [TBL] [Abstract][Full Text] [Related]
10. Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis. Karalilova R; Kazakova M; Sapundzhieva T; Dichev V; Batalov Z; Sarafian V; Batalov A Rheumatol Int; 2019 Nov; 39(11):1841-1848. PubMed ID: 31375891 [TBL] [Abstract][Full Text] [Related]
11. Analysis of serum interleukin(IL)-1α, IL-1β and IL-18 in patients with systemic sclerosis. Lin E; Vincent FB; Sahhar J; Ngian GS; Kandane-Rathnayake R; Mende R; Morand EF; Lang T; Harris J Clin Transl Immunology; 2019; 8(4):e1045. PubMed ID: 30997045 [TBL] [Abstract][Full Text] [Related]
12. IL-13 and IL-33 Serum Levels Are Increased in Systemic Sclerosis Patients With Interstitial Lung Disease. Versace AG; Bitto A; Ioppolo C; Aragona CO; La Rosa D; Roberts WN; D'Angelo T; Cinquegrani A; Cirmi S; Irrera N; Navarra M; Corrao S; Gangemi S; Bagnato G Front Med (Lausanne); 2022; 9():825567. PubMed ID: 35252259 [TBL] [Abstract][Full Text] [Related]
13. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry. Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J; Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608 [TBL] [Abstract][Full Text] [Related]
14. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320 [TBL] [Abstract][Full Text] [Related]
15. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458 [TBL] [Abstract][Full Text] [Related]
16. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis. Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411 [TBL] [Abstract][Full Text] [Related]
18. Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography. D'Alessandro R; Garcia Gonzalez E; Falsetti P; Conticini E; d'Alessandro M; Selvi E; Bellisai F; Berlengiero V; Vallifuoco G; Pata AP; Bardelli M; Baldi C; Cantarini L; Bargagli E; Frediani B Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836844 [TBL] [Abstract][Full Text] [Related]
19. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group. Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341 [TBL] [Abstract][Full Text] [Related]
20. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage. Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]